CSRP2BP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.707200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.899800E-01
Normal-vs-Stage2
6.372000E-01
Normal-vs-Stage3
7.158100E-02
Normal-vs-Stage4
9.895400E-01
Stage1-vs-Stage2
1.665700E-02
Stage1-vs-Stage3
2.652300E-02
Stage1-vs-Stage4
4.686000E-01
Stage2-vs-Stage3
7.297700E-02
Stage2-vs-Stage4
5.764800E-01
Stage3-vs-Stage4
2.516000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.972200E-01
Normal-vs-AfricanAmerican
8.252800E-01
Normal-vs-Asian
2.972800E-01
Caucasian-vs-AfricanAmerican
6.798400E-01
Caucasian-vs-Asian
1.117200E-01
AfricanAmerican-vs-Asian
1.184640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.898800E-01
Normal-vs-Female
8.193000E-01
Male-vs-Female
8.454200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.785000E-01
Normal-vs-Age(41-60Yrs)
9.795600E-01
Normal-vs-Age(61-80Yrs)
7.943800E-01
Normal-vs-Age(81-100Yrs)
8.813000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.761800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.545400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.490800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.647400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.602800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.123600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.500000E-01
Normal-vs-Daily Drinker
6.013600E-01
Normal-vs-Weekly Drinker
6.399000E-01
Normal-vs-Occasional Drinker
8.067000E-01
Normal-vs-Social Drinker
7.634800E-01
Non Drinker-vs-Daily Drinker
7.782400E-01
Non Drinker-vs-Weekly Drinker
8.272600E-01
Non Drinker-vs-Occasional Drinker
6.017500E-02
Non Drinker-vs-Social Drinker
1.672170E-01
Daily Drinker-vs-Weekly Drinker
9.865400E-01
Daily Drinker-vs-Occasional Drinker
1.568600E-01
Daily Drinker-vs-Social Drinker
2.264400E-01
Weekly Drinker-vs-Occasional Drinker
2.283000E-01
Weekly Drinker-vs-Social Drinker
2.587600E-01
Occasional Drinker-vs-Social Drinker
7.464400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.637800E-01
Normal-vs-Grade 2
9.776200E-01
Normal-vs-Grade 3
9.545200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.250230E-01
Grade 1-vs-Grade 3
1.956380E-01
Grade 1-vs-Grade 4
6.637800E-01
Grade 2-vs-Grade 3
6.678000E-01
Grade 2-vs-Grade 4
9.776200E-01
Grade 3-vs-Grade 4
9.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.306800E-01
Normal-vs-NonDiabetic
9.664600E-01
Diabetic-vs-NonDiabetic
1.409230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.423000E-01
Normal-vs-NoPancreatitis
9.258600E-01
Pancreatitis-vs-NoPancreatitis
2.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.327200E-01
Normal-vs-N1
6.884800E-01
N0-vs-N1
2.095400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.781600E-01
Normal-vs-TP53-NonMutant
5.730200E-01
TP53-Mutant-vs-TP53-NonMutant
2.317600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
